BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 34118419)

  • 1. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis.
    van der Zee J; Dillen L; Baradaran-Heravi Y; Gossye H; Koçoğlu C; Cuyt I; Dermaut B; Sieben A; Baets J; De Jonghe P; Vandenberghe R; De Deyn P; Cras P; Engelborghs S; Van Broeckhoven C;
    Neurobiol Dis; 2021 Aug; 156():105421. PubMed ID: 34118419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBM45 homo-oligomerization mediates association with ALS-linked proteins and stress granules.
    Li Y; Collins M; Geiser R; Bakkar N; Riascos D; Bowser R
    Sci Rep; 2015 Sep; 5():14262. PubMed ID: 26391765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases.
    Collins M; Li Y; Bowser R
    Acta Neuropathol Commun; 2020 Jun; 8(1):91. PubMed ID: 32586379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum.
    Baradaran-Heravi Y; Van Broeckhoven C; van der Zee J
    Neurobiol Dis; 2020 Feb; 134():104639. PubMed ID: 31626953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.
    Li Y; Collins M; An J; Geiser R; Tegeler T; Tsantilas K; Garcia K; Pirrotte P; Bowser R
    Brain Res; 2016 Sep; 1647():79-93. PubMed ID: 26979993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    van der Zee J; Gijselinck I; Van Mossevelde S; Perrone F; Dillen L; Heeman B; Bäumer V; Engelborghs S; De Bleecker J; Baets J; Gelpi E; Rojas-García R; Clarimón J; Lleó A; Diehl-Schmid J; Alexopoulos P; Perneczky R; Synofzik M; Just J; Schöls L; Graff C; Thonberg H; Borroni B; Padovani A; Jordanova A; Sarafov S; Tournev I; de Mendonça A; Miltenberger-Miltényi G; Simões do Couto F; Ramirez A; Jessen F; Heneka MT; Gómez-Tortosa E; Danek A; Cras P; Vandenberghe R; De Jonghe P; De Deyn PP; Sleegers K; Cruts M; Van Broeckhoven C; Goeman J; Nuytten D; Smets K; Robberecht W; Damme PV; Bleecker J; Santens P; Dermaut B; Versijpt J; Michotte A; Ivanoiu A; Deryck O; Bergmans B; Delbeck J; Bruyland M; Willems C; Salmon E; Pastor P; Ortega-Cubero S; Benussi L; Ghidoni R; Binetti G; Hernández I; Boada M; Ruiz A; Sorbi S; Nacmias B; Bagnoli S; Sorbi S; Sanchez-Valle R; Llado A; Santana I; Rosário Almeida M; Frisoni GB; Maetzler W; Matej R; Fraidakis MJ; Kovacs GG; Fabrizi GM; Testi S
    Hum Mutat; 2017 Mar; 38(3):297-309. PubMed ID: 28008748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
    McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.
    Diekstra FP; Van Deerlin VM; van Swieten JC; Al-Chalabi A; Ludolph AC; Weishaupt JH; Hardiman O; Landers JE; Brown RH; van Es MA; Pasterkamp RJ; Koppers M; Andersen PM; Estrada K; Rivadeneira F; Hofman A; Uitterlinden AG; van Damme P; Melki J; Meininger V; Shatunov A; Shaw CE; Leigh PN; Shaw PJ; Morrison KE; Fogh I; Chiò A; Traynor BJ; Czell D; Weber M; Heutink P; de Bakker PI; Silani V; Robberecht W; van den Berg LH; Veldink JH
    Ann Neurol; 2014 Jul; 76(1):120-33. PubMed ID: 24931836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R
    Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy.
    Seelen M; Visser AE; Overste DJ; Kim HJ; Palud A; Wong TH; van Swieten JC; Scheltens P; Voermans NC; Baas F; de Jong JM; van der Kooi AJ; de Visser M; Veldink JH; Taylor JP; Van Es MA; van den Berg LH
    Neurobiol Aging; 2014 Aug; 35(8):1956.e9-1956.e11. PubMed ID: 24612671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
    Root J; Merino P; Nuckols A; Johnson M; Kukar T
    Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia.
    Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH
    J Neurol Sci; 2016 Jul; 366():197-201. PubMed ID: 27288806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
    Millecamps S; De Septenville A; Teyssou E; Daniau M; Camuzat A; Albert M; LeGuern E; Galimberti D; ; Brice A; Marie Y; Le Ber I
    Neurobiol Aging; 2014 Dec; 35(12):2882.e13-2882.e15. PubMed ID: 25158920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort.
    Gijselinck I; Van Mossevelde S; van der Zee J; Sieben A; Philtjens S; Heeman B; Engelborghs S; Vandenbulcke M; De Baets G; Bäumer V; Cuijt I; Van den Broeck M; Peeters K; Mattheijssens M; Rousseau F; Vandenberghe R; De Jonghe P; Cras P; De Deyn PP; Martin JJ; Cruts M; Van Broeckhoven C;
    Neurology; 2015 Dec; 85(24):2116-25. PubMed ID: 26581300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.
    Bakkar N; Kousari A; Kovalik T; Li Y; Bowser R
    Mol Cell Biol; 2015 Jul; 35(14):2385-99. PubMed ID: 25939382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.